Synthesis of Mcl-1 inhibitor

US11149024B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11149024-B2
Application numberUS-201816497919-A
CountryUS
Kind codeB2
Filing dateMar 29, 2018
Priority dateMar 31, 2017
Publication dateOct 19, 2021
Grant dateOct 19, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Disclosed are intermediates and methods of synthesizing Compound 1.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound selected from: or a salt thereof. 2. A salt of claim 1 , which is:

Assignees

Inventors

Classifications

  • C07D403/04Primary

    directly linked by a ring-member-to-ring-member bond · CPC title

  • with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms · CPC title

  • C07C245/06Primary

    with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings · CPC title

  • C07C251/76Primary

    to carbon atoms of a saturated carbon skeleton · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11149024B2 cover?
Disclosed are intermediates and methods of synthesizing Compound 1.
Who is the assignee on this patent?
Astrazeneca Ab
What technology area does this patent fall under?
Primary CPC classification C07D403/04. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Oct 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 1 related publication on this page (citations in our corpus or others sharing the same primary CPC).